MX2016016800A - Metodos para el tratamiento del sobrepeso o la obesidad. - Google Patents

Metodos para el tratamiento del sobrepeso o la obesidad.

Info

Publication number
MX2016016800A
MX2016016800A MX2016016800A MX2016016800A MX2016016800A MX 2016016800 A MX2016016800 A MX 2016016800A MX 2016016800 A MX2016016800 A MX 2016016800A MX 2016016800 A MX2016016800 A MX 2016016800A MX 2016016800 A MX2016016800 A MX 2016016800A
Authority
MX
Mexico
Prior art keywords
obesity
methods
subject
treating
treating overweight
Prior art date
Application number
MX2016016800A
Other languages
English (en)
Inventor
Zohar Yishai
Sannino Alessandro
S Ron Eyal
Heshmati Hassan
Original Assignee
Gelesis Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelesis Llc filed Critical Gelesis Llc
Publication of MX2016016800A publication Critical patent/MX2016016800A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se relaciona con metodos de gestion de peso y tratamiento del sobrepeso o la obesidad y tratamiento o prevencion de diabetes en un sujeto que los necesite. En una modalidad, el metodo comprende los pasos de (a) administrar al sujeto por via oral de aproximadamente 0.7 g a aproximadamente 4 g de carboximetilcelulosa reticulada; y (b) administrar al sujeto por via oral al menos aproximadamente 100 ml de agua por gramo de carboximetilcelulosa reticulada. Los pasos (a) y (b) se realizan antes de o con al menos una comida al dia.
MX2016016800A 2014-06-20 2015-06-19 Metodos para el tratamiento del sobrepeso o la obesidad. MX2016016800A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462014926P 2014-06-20 2014-06-20
PCT/US2015/036654 WO2015196054A1 (en) 2014-06-20 2015-06-19 Methods for treating overweight or obesity

Publications (1)

Publication Number Publication Date
MX2016016800A true MX2016016800A (es) 2017-05-03

Family

ID=54868671

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016016800A MX2016016800A (es) 2014-06-20 2015-06-19 Metodos para el tratamiento del sobrepeso o la obesidad.

Country Status (11)

Country Link
US (3) US9855294B2 (es)
EP (1) EP3157536A4 (es)
JP (1) JP6726109B2 (es)
KR (2) KR20230085212A (es)
CN (2) CN115381850A (es)
AU (1) AU2015276889B2 (es)
BR (1) BR112016029713A8 (es)
CA (1) CA2950482C (es)
MX (1) MX2016016800A (es)
RU (1) RU2696494C2 (es)
WO (1) WO2015196054A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010001629A (es) * 2007-08-10 2010-08-09 Alessandro Sannino Hidrogeles de polimero y metodos de preparacion de los mismos.
BR112013031209B1 (pt) * 2011-06-07 2020-11-24 Gelesis Llc Metodo para produzir hidrogeis
KR20230085212A (ko) 2014-06-20 2023-06-13 젤레시스 엘엘씨 과체중 또는 비만 치료 방법
CN107250164B (zh) 2015-01-29 2023-01-31 吉莱斯公司 用于制造结合高弹性模量和吸收性的水凝胶的方法
US10945974B2 (en) 2015-06-01 2021-03-16 Xeno Biosciences Inc. Methods and compositions to modulate the gut microbiota and to manage weight
RU2745992C2 (ru) * 2016-04-25 2021-04-05 Джелесис ЭлЭлСи Способ лечения запора
WO2017213961A1 (en) * 2016-06-10 2017-12-14 Gelesis Llc Methods of inducing weight loss, treating obesity and preventing weight gain
EP3468670B1 (en) 2016-06-10 2023-12-13 University of Copenhagen Predetermined diet for use in inducing weight loss and preventing weight gain
US11311573B2 (en) 2016-11-30 2022-04-26 Xeno Biosciences Inc. Pharmaceutical preparations and methods to manage weight and to modulate the gut microbiota
RU2019135202A (ru) * 2017-04-05 2021-05-05 Джелесис ЭлЭлСи Улучшенные сверхвпитывающие материалы и способы их получения
US10695363B2 (en) * 2017-04-14 2020-06-30 Gelesis Llc Compositions and methods for treating or preventing gut permeability-related disorders
US11918602B2 (en) 2018-08-10 2024-03-05 Simeon Investment, Inc. Methods for reducing cholesterol with superabsorbent materials
US11925660B2 (en) 2018-08-10 2024-03-12 Simeon Investment, Inc. Treatment for obesity with superabsorbent materials
WO2021067076A1 (en) * 2019-10-01 2021-04-08 Brillian Pharma Inc. Methods for treating or preventing obesity and body weight management
RU2749484C1 (ru) * 2020-06-18 2021-06-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО УГМУ Минздрава России) Способ оценки массы тела человека
CN115335412B (zh) * 2021-03-23 2024-04-23 厦门君德医药科技有限公司 超吸收性水凝胶
CN114009797A (zh) * 2021-11-17 2022-02-08 上海市第十人民医院 一种减肥组合物及其制备方法和应用
CN114381014B (zh) * 2021-12-16 2023-02-17 佑道(天津)健康咨询有限公司 一种可生物降解的水凝胶及其应用
CN114702734A (zh) * 2022-04-08 2022-07-05 重庆师范大学 一种纤维素醚类凝胶及其制备方法和应用
CN116807980A (zh) * 2023-07-10 2023-09-29 橡果美健实业投资股份有限公司 用于肥胖干预的胃内占容水凝胶颗粒的制备方法及应用

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE212969C (es)
US3526048A (en) 1967-06-07 1970-09-01 Us Agriculture Cellulose fibers cross-linked and esterified with polycarboxylic acids
DD212969A1 (de) 1982-12-30 1984-08-29 Adw Inst Polymerenchemie Verfahren zur modifizierung von carboxymethylcellulose
JPS62141001A (ja) 1985-12-13 1987-06-24 Dai Ichi Kogyo Seiyaku Co Ltd 水不溶性のカルボキシアルキルセルロ−ス・アルカリ金属塩の製造方法
JPH01187048A (ja) 1988-01-18 1989-07-26 Dai Ichi Kogyo Seiyaku Co Ltd 糠漬け用組成物
US5137537A (en) 1989-11-07 1992-08-11 The Procter & Gamble Cellulose Company Absorbent structure containing individualized, polycarboxylic acid crosslinked wood pulp cellulose fibers
JPH05507948A (ja) 1990-04-18 1993-11-11 ユニバーシティ オブ ユタ リサーチ ファウンデーション アゾ結合を含み、ｐＨ依存性膨潤を示す、架橋したヒドロゲルに基づいた、結腸を標的にした経口薬の投薬形態
GB9017800D0 (en) 1990-08-14 1990-09-26 Unilever Plc Moisture barrier and its preparation
US5247072A (en) 1991-10-25 1993-09-21 Kimberly-Clark Corporation Carboxyalkyl polysaccharides having improved absorbent properties and process for the preparation thereof
US5550189A (en) 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
SK281042B6 (sk) 1992-09-18 2000-11-07 Yamanouchi Pharmaceutical Co., Ltd Prípravok hydrogélového typu s ustáleným uvoľňovaním
JP3274550B2 (ja) 1993-08-03 2002-04-15 株式会社日本触媒 吸水材の製法
AU1987495A (en) 1994-03-18 1995-10-09 Procter & Gamble Company, The Preparing individualized polycarboxylic acid crosslinked cellulosic fibers
AU3274895A (en) 1994-07-18 1996-02-16 Gel Sciences, Inc. Novel polymer gel networks and methods of use
CN1095643C (zh) 1994-12-09 2002-12-11 普罗克特和甘保尔公司 吸收性复合材料、其制备方法及包含该材料的吸收用品
US20010006677A1 (en) 1996-10-29 2001-07-05 Mcginity James W. Effervescence polymeric film drug delivery system
DE19654745C5 (de) 1996-12-30 2004-01-22 Lechner, M.D., Prof. Dr. Biologisch abbaubares Absorptionsmittel, dessen Herstellung und Verwendung
US6271278B1 (en) 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
AU3561697A (en) 1997-06-24 1999-01-04 Sca Molnlycke Ab Absorbent polymer material based on renewable starting materials
CO5070628A1 (es) 1997-11-25 2001-08-28 Kimberly Clark Co Espuma absorbente que comprende un polimero, el producto absorbente que la comprende y el proceso para su preparacion
WO2000032064A1 (en) 1998-11-30 2000-06-08 Hercules Incorporated Controlled release carbohydrate embedded in a crosslinked polysaccharide
TNSN99243A1 (fr) 1998-12-16 2001-12-31 Sca Hygiene Prod Zeist Bv Polysaccharides superabsorbants acides
US6471824B1 (en) 1998-12-29 2002-10-29 Weyerhaeuser Company Carboxylated cellulosic fibers
US6867346B1 (en) 1999-09-21 2005-03-15 Weyerhaeuser Company Absorbent composite having fibrous bands
EP1134232A1 (en) 2000-03-16 2001-09-19 SCA Hygiene Products AB Polysaccharide-based superabsorbent film
JP2003533285A (ja) 2000-05-15 2003-11-11 キンバリー クラーク ワールドワイド インコーポレイテッド 多糖類吸収体及び方法
US6472006B1 (en) 2001-04-05 2002-10-29 Kraft Foods Holdings, Inc. Oven-stable edible moisture barrier
DE10125599A1 (de) 2001-05-25 2002-11-28 Stockhausen Chem Fab Gmbh Superabsorber, Verfahren zu ihrer Herstellung und ihre Verwendung
ES2271287T3 (es) 2001-06-28 2007-04-16 Basf Aktiengesellschaft Hidrogeles acidos altamente capaces de hincharse.
JP4132993B2 (ja) 2002-06-03 2008-08-13 住友精化株式会社 吸水性樹脂およびその製造方法
US7648619B2 (en) 2002-06-04 2010-01-19 Industrial Technology Research Hydrogel-driven micropump
WO2004056343A1 (en) 2002-12-19 2004-07-08 Polymorfix, Inc. Ingestible formulations for transient, noninvasive reduction of gastric volume
NL1023257C2 (nl) 2003-04-24 2004-10-27 Tno Vochtwerende bekledingslaag voor voedingsmiddelen.
CA2584188C (en) 2003-10-16 2014-03-18 Techcom Group, Llc Reduced digestible carbohydrate food having reduced blood glucose response
US8128958B2 (en) 2003-11-10 2012-03-06 Astellas Pharma Inc. Sustained release pharmaceutical composition
US20050143571A1 (en) 2003-12-30 2005-06-30 Weyerhaeuser Company Method for forming individualized intrafiber crosslinked cellulosic fibers with improved brightness and color
US8580953B2 (en) 2004-06-21 2013-11-12 Evonik Degussa Gmbh Water-absorbing polysaccharide and method for producing the same
WO2006061087A1 (en) 2004-12-08 2006-06-15 Unilever Plc Satiety enhancing food product and a method for manufacturing such
US20060142480A1 (en) 2004-12-29 2006-06-29 Mengkui Luo Method of making carboxyalkyl cellulose polymer network
US20060142478A1 (en) 2004-12-29 2006-06-29 Mengkui Luo Carboxyalkyl cellulose polymer network
ITTO20040918A1 (it) 2004-12-29 2005-03-29 Luigi Ambrosio Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione
JP5638736B2 (ja) 2004-12-30 2014-12-10 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション 腸の健康を改善する方法および手段
US11744803B2 (en) 2005-07-29 2023-09-05 Stichting Groningen Centre for Drug Rese PH-controlled pulsatile delivery system, methods for preparation and use thereof
JP2009531462A (ja) 2006-03-28 2009-09-03 ジェレシス， インク． 性能向上のためのポリマ材料と他の物質との併用
EP2007351A2 (en) 2006-03-30 2008-12-31 Gelesis, Inc. Polymeric materials as stomach filler and their preparation
WO2007115169A2 (en) 2006-03-30 2007-10-11 Gelesis, Inc. Polymeric materials as stomach filler and their preparation
GB2445818B8 (en) 2006-09-15 2011-06-22 Japan Atomic Energy Agency Preparation of gels derived from carboxymethyl cellulose alkali metal salt
JP4288618B2 (ja) 2006-09-15 2009-07-01 独立行政法人 日本原子力研究開発機構 カルボキシメチルセルロースゲルの製造方法
US20080147026A1 (en) 2006-12-15 2008-06-19 Jian Qin Absorbent fiber with a low absorbent capacity and slow absorption rate
JP2008195649A (ja) 2007-02-13 2008-08-28 Daicel Chem Ind Ltd 害虫防除用ベイト剤及びその製造方法
US10716828B2 (en) * 2007-05-02 2020-07-21 Dana-Farber Cancer Institute, Inc. Methods of modulating cellular homeostatic pathways and cellular survival
JP2008285611A (ja) 2007-05-18 2008-11-27 Daicel Chem Ind Ltd 架橋ゲルの製造方法及びその架橋ゲル
MX2010001629A (es) 2007-08-10 2010-08-09 Alessandro Sannino Hidrogeles de polimero y metodos de preparacion de los mismos.
US8039683B2 (en) 2007-10-15 2011-10-18 Kimberly-Clark Worldwide, Inc. Absorbent composites having improved fluid wicking and web integrity
US9345809B2 (en) 2007-11-28 2016-05-24 Fziomed, Inc. Carboxymethylcellulose polyethylene glycol compositions for medical uses
CN102281771A (zh) * 2008-11-18 2011-12-14 万有限责任公司 用于体重管理和改善血糖控制的方法和组合物
RU2441654C2 (ru) * 2010-02-17 2012-02-10 Лабораториос Баго С.А. Фармацевтическая композиция с активностью против ожирения, включающая премикс чистого орлистата, и способ ее изготовления
BR112013031209B1 (pt) 2011-06-07 2020-11-24 Gelesis Llc Metodo para produzir hidrogeis
KR20230085212A (ko) 2014-06-20 2023-06-13 젤레시스 엘엘씨 과체중 또는 비만 치료 방법
CN107250164B (zh) 2015-01-29 2023-01-31 吉莱斯公司 用于制造结合高弹性模量和吸收性的水凝胶的方法
RU2745992C2 (ru) 2016-04-25 2021-04-05 Джелесис ЭлЭлСи Способ лечения запора

Also Published As

Publication number Publication date
RU2016148609A (ru) 2018-07-20
US20210260099A1 (en) 2021-08-26
CN115381850A (zh) 2022-11-25
RU2016148609A3 (es) 2019-01-17
CA2950482A1 (en) 2015-12-23
RU2696494C2 (ru) 2019-08-02
US20180153925A1 (en) 2018-06-07
AU2015276889B2 (en) 2019-04-18
EP3157536A1 (en) 2017-04-26
US9855294B2 (en) 2018-01-02
CA2950482C (en) 2022-12-06
BR112016029713A2 (pt) 2017-08-22
KR20170029432A (ko) 2017-03-15
CN106470689A (zh) 2017-03-01
WO2015196054A1 (en) 2015-12-23
US20150366898A1 (en) 2015-12-24
BR112016029713A8 (pt) 2021-07-20
EP3157536A4 (en) 2018-01-24
US11628184B2 (en) 2023-04-18
US10953038B2 (en) 2021-03-23
JP2017519751A (ja) 2017-07-20
KR20230085212A (ko) 2023-06-13
AU2015276889A1 (en) 2016-11-24
JP6726109B2 (ja) 2020-07-22

Similar Documents

Publication Publication Date Title
MX2016016800A (es) Metodos para el tratamiento del sobrepeso o la obesidad.
MX2016013243A (es) Agonistas peptídicos duales de los receptores de glp-1/glucagón derivados de la exendina-4.
MX2016013248A (es) Agonistas duales del receptor de glp-1/glucagon derivados de exendina-4.
MX2016013244A (es) Derivados de exendina-4 como agonistas peptidicos duales del receptor de glp-1/glucagon.
PH12015502310B1 (en) Pharmaceutical composition, methods for treating and uses thereof
MY179105A (en) Methods of treating alzheimer's disease
PH12019501018A1 (en) Pharmaceutical composition, methods for treating and uses thereof
PH12018500578A1 (en) Methods of treating inflammatory diseases
EP3164125B8 (en) Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes
MX2019010594A (es) Beta-caseina a2 y prevencion de la inflamacion del intestino.
MA39710A (fr) Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
EA201790475A1 (ru) Способы лечения системной красной волчанки с использованием доменного антитела против cd28
MX2014005765A (es) Compuestos triciclicos, composiciones que los comprenden y usos de los mismos.
NZ738100A (en) Igfbp3 and uses thereof
MX2016009278A (es) Composicion que comprende okra para utilizarse en reducir la absorcion de grasas dieteticas.
WO2016057683A3 (en) Novel anti-nodal antibodies and methods of using same
WO2017035176A8 (en) Method of preventing or treating obesity with an emc10 inhibitor
SG10201811078XA (en) Method Of Treatment Of Hypoxia Inducible Factor (HIF)-Related Conditions
IL256329B (en) Carbazole derivatives for the treatment of fibrotic diseases, symptoms and conditions related to them
PH12015502100A1 (en) Reducing the risk of autoimmune disease
WO2016027029A3 (fr) Procédé pour déterminer le pronostic de survie d'un patient atteint d'un cancer du pancréas
MX2017002277A (es) Anticuerpos que potencian el factor h y sus usos.
MX2016013588A (es) Complejo de tanato de sitagliptina.
MX362391B (es) Métodos de tratamiento de enfermedad renal y otros trastornos.
MX2019002647A (es) Composiciones de tesofensina.